Onconetix prices USD 30.25 million PIPE via Series F convertible preferred stock sale
Reuters2026/07/29 21:22- Onconetix entered a $30.25 million PIPE on July 28, 2026 through an unregistered sale of 37,812 shares of Series F convertible preferred stock.
- Series F carries a $1,000 stated value per share, convertible into common stock at an initial conversion price of $0.98.
- Registration rights granted for common shares issuable on conversion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Xenia Hôtellerie Solution announces extraordinary shareholder meeting
Community Reacts As Pundit Claims XRP Will Be Priced At $2,953 By Q2 2027
Colgate-Palmolive (CL.US) plans to sell part of its personal care brands, with a total transaction amount possibly exceeding 1.1 billions USD.
According to sources familiar with the matter, Colgate is exploring the sale of some of its mass-market personal care brands. The company currently plans to divest only a few brands within its personal care business, and the combined sale price may exceed 1 billion dollars.
EdiliziAcrobatica announces shareholder meeting notice
Crypto prices
More
